Findings

What do systematic reviews say?

165 questions · 165 findings · 18 reviews

No studies found 65 · 39.4%GRADE not reported 6 · 3.6%Very low 25 · 15.2%Low 31 · 18.8%Moderate 33 · 20%High 5 · 3%

Adverse effects · patients with status epilepticus

Lorazepam IV showed no clear difference in adverse effects compared with diazepam plus phenytoin IV (moderate certainty).

1 finding from 1 review

Anticonvulsant therapy for status epilepticus 2014 · Cochrane Headline outcomes only
RR 0.85 [0.63, 1.15]
2 studies · 370 participants
Moderate

Deaths · patients with status epilepticus

1 finding from 1 review

Anticonvulsant therapy for status epilepticus 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 178 participants
GRADE not reported

Requirement for ventilatory support · patients with status epilepticus

1 finding from 1 review

Anticonvulsant therapy for status epilepticus 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 178 participants
GRADE not reported

Number improved at one year · Patients with pelvic floor dyssynergia and chronic constipation

It is very uncertain whether EMG biofeedback changes number improved at three months compared with diazepam (very low certainty).

1 finding from 1 review

Biofeedback for treatment of chronic idiopathic constipation in adults 2014 · Cochrane Headline outcomes only
RR 3 [1.51, 5.98]
1 study · 60 participants
Very low

AW symptoms (CIWA‐Ar score) · people with alcohol withdrawal

1 finding from 1 review

Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses 2010 · Cochrane Headline outcomes only
no estimate extracted
1 study · 48 participants
Very low